123 related articles for article (PubMed ID: 9056005)
1. Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis.
Klepser ME; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1997 Mar; 41(3):630-5. PubMed ID: 9056005
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection.
Lewis RE; Klepser ME; Ernst EJ; Lund BC; Biedenbach DJ; Jones RN
Antimicrob Agents Chemother; 1999 Aug; 43(8):2005-9. PubMed ID: 10428927
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
Klepser ME; Marangos MN; Zhu Z; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1997 Feb; 41(2):435-9. PubMed ID: 9021203
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
[TBL] [Abstract][Full Text] [Related]
5. Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.
Klepser ME; Banevicius MA; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1996 Aug; 40(8):1941-4. PubMed ID: 8843310
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Rybak MJ; Houlihan HH; Mercier RC; Kaatz GW
Antimicrob Agents Chemother; 1997 Jun; 41(6):1359-63. PubMed ID: 9174199
[TBL] [Abstract][Full Text] [Related]
7. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection.
Lewis RE; Klepser ME; Ernst EJ; Snabes MA; Jones RN
Diagn Microbiol Infect Dis; 2000 May; 37(1):51-5. PubMed ID: 10794941
[TBL] [Abstract][Full Text] [Related]
10. Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.
Xue IB; Davey PG; Phillips G
Antimicrob Agents Chemother; 1996 Jun; 40(6):1403-7. PubMed ID: 8726009
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
Santoro J; Kaye D; Levison ME
Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
[TBL] [Abstract][Full Text] [Related]
12. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.
Flaherty JF; Rodondi LC; Guglielmo BJ; Fleishaker JC; Townsend RJ; Gambertoglio JG
Antimicrob Agents Chemother; 1988 Dec; 32(12):1825-9. PubMed ID: 3245695
[TBL] [Abstract][Full Text] [Related]
14. Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid.
Schaadt RD; Batts DH; Daley-Yates PT; Pawsey SD; Stalker DJ; Zurenko GE
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):201-4. PubMed ID: 9327249
[TBL] [Abstract][Full Text] [Related]
15. Cross-over assessment of serum bactericidal activity of moxifloxacin and levofloxacin versus penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in healthy volunteers.
Hart D; Weinstein MP
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):375-8. PubMed ID: 17449210
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
Cappelletty DM; Rybak MJ
Antimicrob Agents Chemother; 1996 May; 40(5):1148-52. PubMed ID: 8723456
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations and ex vivo inhibitory/bactericidal activity of clindamycin after administration of two oral dosages.
Dan M; Yampolsky E; Poch F
Chemotherapy; 1997; 43(4):227-31. PubMed ID: 9209778
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae.
Patel R; Rouse MS; Piper KE; Cockerill FR; Steckelberg JM
Diagn Microbiol Infect Dis; 1998 Feb; 30(2):89-92. PubMed ID: 9554174
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis group.
Aldridge KE; Stratton CW
J Antimicrob Chemother; 1991 Nov; 28(5):701-5. PubMed ID: 1778873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
